An assessment of clinically optimal gold marker length and diameter for pelvic radiotherapy verification using an amorphous silicon flat panel electronic portal imaging device

British Journal of Radiology

Volumn 78, Issue 932, 2005, Pages 737-741

  Henry, Ann M ^a   Stratford, J ^a   Davies, J ^a   McCarthy, C ^a   Swindell, R ^b   Sykes, J ^b   Moore, C J ^b   Price, P ^a   Khoo, V S ^a,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL PROTOCOL; ELECTRONIC SENSOR; HUMAN; IMAGE QUALITY; IMAGING SYSTEM; LINEAR ACCELERATOR; MALE; PELVIS; PROSTATE CANCER; RADIATION BEAM; SCORING SYSTEM;

ELECTRONICS, MEDICAL; GOLD; HUMANS; MOVEMENT; OBSERVER VARIATION; PELVIC NEOPLASMS; PELVIS; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; SILICON;

EID: 23744447763     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/97956788     Document Type: Article

References (18)

1. www.CancerResearchUK.org 1999 Cancer Statistics. [Accessed 26 April 2005].
2. Zelefsky MJ, Leibel SA, Gaudin PB, Kutcher GJ, Fleshner NE, Venkatramen ES, et al. Dose escalation with three dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998;41:491-500.
3. Pollack A, Zagars GK, Smith LG, Lee JJ, von Eschenbach AC, Antolak JA, et al. Preliminary results of a randomised radiotherapy dose escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol 2000;18:3904-11.
4. Dearnaley DP, Khoo VS, Norman AR, Meyer L, Nahum A, Tait D, et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 1999;353:267-72.
5. Langen KM, Jones DTL. Organ motion and its management. Int J Radiat Oncol Biol Phys 2001;50:265-78.
6. Pouliot J, Aubin M, Langen KM, Liu YM, Pickett B, Shinohara K, et al. (Non)-migration of radiopaque markers used for on-line localization of the prostate with an electronic portal imaging device. Int J Radiat Oncol Biol Phys 2003;56:862-6.
7. Herman MG, Pisansky TM, Kruse JJ, Prisciandaro JI, Davis BJ, King BF. Technical aspects of daily online positioning of the prostate for three-dimensional conformal radiotherapy using an electronic portal imaging device. Int J Radiat Oncol Biol Phys 2003;57:1131-40.
8. Zelefsky MJ, Leibel SA, Burman CM, Kutchner GJ, Harrison A, Happersett L, et al. Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 1994;29:755-61.
9. Nederveen AJ, Lagendijk JJW, Hofman P. Feasibility of automatic detection systems with an a-Si flat-panel imager. Phys Med Biol 2001;46:1219-30.
10. Crook JM, Raymond Y, Salhani D, Yang H, Esch B. Prostate motion during standard radiotherapy as assessed by fiducial markers. Radiother Oncol 1995;37:35-42.
11. Balter JM, Lam KL, Sandler HM, Littles JF, Bree RL, Ten Halken RK. Automated localization of the prostate at the time of treatment using implanted radiopaque markers: technical feasibility. Int J Radiat Oncol Biol Phys 1995;33:1281-6.
12. Vigneault E, Pouliot J, Laverdiere J, Roy J, Dorion M. Electronic portal imaging device detection of radioopaque markers for the evaluation of prostate position during megavoltage irradiation: a clinical study. Int J Radiat Oncol Biol Phys 1997;37:205-12.
13. Alasti H, Petric MP, Catton CN, Warde PR. Portal imaging for evaluation of daily on-line setup errors and off-line organ motion during conformal irradiation of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 2001;49:869-84.
14. Litzenberg D, Dawson LA, Sandler H, Sanda MG, McShan DL, Ten Haken RK, et al. Daily prostate targeting using implanted radiopaque markers. Int J Radiat Oncol Biol Phys 2002;52:699-703.
15. Poggi MM, Gant DA, Sewchand W, Warlick WB. Marker seed migration in prostate localization. Int J Radiat Oncol Biol Phys 2003;56:1248-51.
16. Shirato H, Harada T, Harabayashi T, Hida K, Endo H, Kitamura K, et al. Feasibility of insertion/implantation of 2.0 mm diameter gold internal fiducial markers for precise setup and real-time tumor tracking in radiotherapy. Int J Radiat Oncol Biol Phys 2003;56:240-7.
17. Dehnad H, Nederveen AJ, Van der Heide UA, Van Moorselaar RJA, Hofman P, Lagendijk JJW. Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage radiation. Radiother Oncol 2003;67:295-302.
18. Sykes J, Whitehurst P, Moore C. Automatic detection with confidence of implanted radiographic seeds at megavoltage energies using an amorphous silicon imager. Proc SPIE 2003;5029:319-29.